Drawing for CO-PRO

USPTO serial 79286861

CO-PRO

Reviewed by CopyMark Law Group

Reg. 7057590Status 700Registered
Filing date
Status date
Registration date
May 23, 2023
Examiner
BECHHOFER, YOCHEVED D
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CO-PRO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David Postolski

David Postolski Gearhart Law41 River RoadSummit, NJ 07901UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009downloadable mobile apps for interacting with patients, medical treatment and testing of patients, and for remote assistance with patients and patient engagement namely, for diagnosing and treating patients; computer software applications, downloadable, for interacting with patients, and for remote assistance with patients and patient engagement namely, for diagnosing and treating patients; downloadable software and applications for mobile devices; downloadable applications for use with mobile devices for interacting with patients, , and for remote assistance with patients and patient engagement namely, for diagnosing and treating patients; downloadable mobile applications for the transmission of data for interacting with patients, remote assistance with patients and patient engagement; optical data carriers bearing recorded software for interacting with patients, and for remote assistance with patients and patient engagement namely, diagnosing and treating patientsACTIVE—
010Medical devices, namely, diagnostic devices for interacting with patients, medical treatment and testing of patients, namely, blood pressure monitors, blood glucose monitors, sphygmomanometers and clinical thermometers; medical device for remote assistance with patients and patient engagement, and for diagnosing and treating patients, namely, blood pressure monitors, blood glucose monitors, sphygmomanometers and clinical thermometers; medical apparatus, namely, respiratory sensors for measuring breathing and blood pressure monitors; probes for medical purposes, namely, medical ultrasound apparatus and medical instruments to measure blood pressure and cardiac output; medical implants, namely, implantable medical device for monitoring body function; medical instruments, namely, bone, lip, and surgical retractors; medical imaging apparatus; medical support hosiery, namely, support pantyhose; analyzers for medical use, namely, medical diagnostic apparatus for analyzing and measuring patient breathing and body temperature; medical examination lamps; electronic medical instruments, namely, medical diagnostic apparatus for analyzing and measuring patient breathing; electro medical instruments, namely, probes and sensors for measuring body functions, cardiac activity for medical diagnostic purposes; medical radiation apparatus; medical respiratory monitors for sports activities; medical apparatus, namely, spirometer mouth pieces and tubing; tools for medical diagnostics, namely, probes and biofeedback sensors for measuring body functions and cardiac activity; cabinets adapted to hold medical instruments; medical procedure chairs; medical procedure tables; medical compression tights; flexible medical endoscopes; rigid medical endoscopes; medical knee braces; medical elbow braces; blood pressure transducers; spatulas for medical use; boots for medical purposes; surgical cutlery; support mattresses for medical use; needles for medical purposes; scanners for medical diagnostic purposes for measuring body functions, and cardiac activity, namely, ultrasound diagnostic apparatus; electromedical diagnostic instruments, namely, ultrasound diagnostic apparatus featuring sensors for measuring body functions, and cardiac activity; Medical instrument for cardiovascular diagnostics; medical diagnostic instruments for ophthalmology; medical endoscopes for diagnostic use; medical X-ray diagnostic apparatus; medical diagnostic saliva pads; percussion hammers for diagnostic purposes; diagnostic, examination, and monitoring equipment, namely, patient monitoring sensors for measuring body functions, and cardiac activity; magnetic resonance imaging apparatus for medical purposesACTIVE—
042software development, programming and implementation; pharmaceutical drug development services; medical laboratory services; scientific research for medical purposes; research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; provision of information and data relating to medical and veterinary research and development; providing information about scientific and medical research in the field of medical disorders and their treatment, namely, in the field of cardiac activity; design and development of medical diagnostic apparatus; medical research; medical and pharmacological research services; medical research laboratory services; biological research, clinical research in the field of patient engagement and medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; analysis of human serum for medical research; blood analysis services for scientific research purposes; software development; computer software design; software design and development; computer software consultancy; conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; providing information on clinical studies via an interactive website; providing information about the results of clinical trials for pharmaceutical products; chemical technological research; technological research relating to computers; platform services (PaaS), namely, providing online non-downloadable software for interacting with patients, and for remote assistance with patients and patient engagement, namely, for measuring body functions, cardiac activity and ultrasound purposes; software services (SaaS), namely, providing online non-downloadable software for interacting with patients, medical treatment and testing of patients, and for remote assistance with patients and patient engagement, namely, for measuring body functions, cardiac activity and ultrasound purposes; scientific research services for medical purposes; all aforementioned services with the express exclusion of services in the field of real estate affairs, including in particular the development, planning, designing, construction, building, financing, managing, marketing, renting, selling and purchasing of real estateACTIVE—
044Medical assistance; medical clinic services; telediagnosis of diseases; disease telediagnosis services; animal healthcare services; medical advisory services related to patients, medical treatment and testing of patients; provision of medical services; human healthcare services; medical examinations; medical treatment services; medical health assessment services; medical advisory services relating to medical problems; medical house call services; medical and healthcare services; providing information relating to medical services; medical treatment services provided by clinics and hospitals; consultancy and information services relating to medical products; patient consultancy and information services in the field of medical treatment and medical testing of patients; medical services for the treatment of conditions of the human body; medical services for the diagnosis of conditions of the human body; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; managed health care services; medical services; home health care services; medical and healthcare clinics; consulting services relating to health care, namely, consulting in the field of medical treatment and testing of patients; medical health care consultancy services, namely, consulting in the field of medical treatment and testing of patients; health care in the nature of health maintenance organizations; medical care; palliative care; nursing care; advisory services relating to weight reduction, namely, consulting to individuals and communities engaged in group weight loss programs; veterinary services; Medical, physical rehabilitation and physical therapy services; dentistry services; psychiatric services; hospital services; chiropractics; homeopathic medical clinical services; beauty salons; barber services; physical therapy; opticians' services; services of a psychologist; sports medicine services; conducting medical physical evaluations; providing medical information; medical counseling; medical analysis services relating to the treatment of patients; pharmaceutical advice; mental health services; telemedicine services; preparation of prescriptions by pharmacistsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 12, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 23, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 23, 2023FIMPFINAL DISPOSITION PROCESSED—
Aug 23, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 23, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 23, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 7, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 7, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2023GPNXNOTIFICATION PROCESSED BY IB—
Feb 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 15, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 27, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jan 27, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 27, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 27, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 26, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 25, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 25, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 14, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jul 10, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 10, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 10, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 9, 2022DOCKASSIGNED TO EXAMINER—
Nov 28, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 10, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 10, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 12, 2021LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Jun 19, 2021LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 3, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 3, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 3, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 7, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 1, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 1, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 1, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 1, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 1, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 30, 2020RFNTREFUSAL PROCESSED BY IB—
Aug 7, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 7, 2020RFRRREFUSAL PROCESSED BY MPU—
Jul 3, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 1, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 30, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 5, 2020DOCKASSIGNED TO EXAMINER—
Jun 5, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance